Ghana Medical Trust Fund (GMTF) is exploring a strategic partnership with Atlantic Lifesciences Limited and the PharmaNova Group to locally manufacture critical medicines for cancer, cardiovascular diseases and other chronic conditions.

🇬🇭 Here's What Happened

The move could significantly reduce the cost of treatment for thousands of Ghanaians.

The discussions form part of the Trust Fund’s drive to secure essential medicines at more affordable prices, reduce Ghana’s dependence on costly imports and ensure that every cedi available to the Trust Fund can support more patients in need of specialised healthcare.

Administrator of the Ghana Medical Trust Fund, Adjoa Obuobia Darko-Opoku, led a team from the Trust Fund on a working visit to Atlantic Lifesciences Limited to inspect its facilities, assess its capabilities and identify practical areas for collaboration.

📌 Key Details

The visit followed an earlier engagement by Atlantic Lifesciences and its partners at the GMTF offices, where initial discussions were held on how the private pharmaceutical sector could support the mandate of the Trust Fund.

At the heart of the latest discussions was a major question: How can Ghana make life-saving medicines more affordable for patients while reducing the burden of imported medicines on the healthcare system?

A statement copied to the Ghana News Agency in Accra said one of the solutions being explored is the local manufacture of a wide range of cardiovascular medicines, anti-cancer medications and immuno suppressants to support the next phase of the GMTF services package.

For the Trust Fund, the potential impact is significant. Producing selected medicines locally could reduce import-related costs, improve the availability of essential drugs and enable the Fund to use its resources to support a greater number of patients battling chronic and life-threatening diseases.

The initiative also aligns with government’s broader vision of strengthening Ghana’s pharmaceutical manufacturing capacity and building a more resilient and self-sufficient healthcare system.

Speaking during the engagement, Dhanankay Tripathi, CEO of PharmaNova Ltd., stressed the importance of identifying gaps within Ghana’s healthcare system and developing practical solutions that directly respond to the needs of patients.

📰 Source: Joy Online Ghana